Found 1905 clinical trials
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
This study will compare the effectiveness of osimertinib alone with the combination of osimertinib and chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a
- 0 views
- 14 Apr, 2021
- 11 locations
Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
inferior to lobectomy for cT1N0M0 non-small-cell lung cancer or not.
- 0 views
- 22 Jan, 2021
- 1 location
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
This study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer. The main aims of this study are to check if there are any side
- 0 views
- 31 May, 2021
- 98 locations
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.
- 284 views
- 13 Jun, 2021
- 147 locations
KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer
This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously received systemic treatment.
- 0 views
- 26 Jan, 2021
- 1 location
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
Non Small Cell lung cancer (NSCLC) remains the first cause of death by cancer in the World. For the patients presenting a NSCLC stage IV, the median of survival is about 15 months today. The
- 22 views
- 25 Jan, 2021
- 46 locations
Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer Patients
This is a Phase III, randomized, placebo-controlled, double-blind, multi-center study assessing the efficacy and safety of durvalumab with SoC SBRT versus placebo with SoC SBRT in patients with unresected clinical Stage I/II lymph node-negative (T1 to T3N0M0) NSCLC.
- 68 views
- 28 Apr, 2021
- 227 locations
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
The purpose of this study is to improve early detection of treatable relapse of lung cancer and thereby improve survival and quality of life for the patients. The investigators will perform a
- 0 views
- 26 Jan, 2021
- 3 locations
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone
- 10 views
- 07 Nov, 2020
- 1 location
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).
- 27 views
- 02 Jun, 2021
- 308 locations